午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Heart stent abuse? The health and family planning commission said
 
Author:中國銘鉉 企劃部  Release Time:2017-8-18 11:08:48  Number Browse:686
 
On August 18, the medical website said, "on average, five or six stents were placed in the heart of each patient." As one of the main treatments for cardiovascular disease, countless heart stent operations are now being questioned. 
 
August 15, the national health and family planning commission for the first time publicly, to "the heart stents abuse" gave the response, said China's average stent in patients with a single number is 1.5, and each treated with interventional therapy under the national quality control system, there is no heart stents to abuse. 
 
Last year, 660,000 cases of heart stent surgery were nearly 20 percent more than in 2015 
 
According to the China cardiovascular disease report 2016, cardiovascular death accounts for the first time in urban and rural areas, with 45 percent of rural residents and 42 percent of cities. The death rate continues to rise as a "number one killer" of cardiovascular disease as a threat to residents' health. 
 
"With the increasing prevalence of cardiovascular risk factors such as hypertension, the incidence and number of cardiovascular diseases in the next 10 years will increase further." Gao yunlin, a famous cardiologist and academician of the Chinese academy of engineering, predicted. 
 
Coronary intervention is known as a "milestone" in the history of cardiovascular disease treatment. Intervention treatment through femoral artery thighs or wrist radial artery, the blood vessels puncture put stent or other device in the coronary arteries, to relieve coronary artery stenosis, is commonly known as the heart stents. 
 
The interventional treatment technology was introduced in China in 1985 and has been slow for some time and accelerated in the past decade, gao said. According to statistics, the number of interventional therapy in China has increased year by year since 2009. According to the latest data from the national health and family planning commission, in 2016, there were more than 660,000 cases of coronary intervention in China, up 17.42 percent from 2015. 
 
"The United States is between 800,000 and 900,000 cases a year, the world's number one, and we are the second largest in the world, with 426 people per million people on average." Run-lin gao told covers news, after more than ten years high speed development, interventional therapy in our country has spread to the county hospital level, "the past county hospital (technology), () of interventional therapy in recent years to 1000, the county hospital development has greatly increased the accessibility of the patient." 
 
Heart stent abuse? NHFPC: 1.5 stents per person 
 
Heart stents in coronary intervention operation is a metal support, it is considered to be the world's most expensive metal - the only 2 or 3 mm in diameter, length, just a few centimeters of the hollow stainless steel cylinder, only a single material price is in ten thousand yuan of above at least. 
 
Think have a view on the basis of interventional therapy is development speed "amazing", the root cause lies in the high profits, "at home to install a heart stent, patients to pay several times higher than the factory price or even more than ten times as much money." Medical institutions are driven by interest, resulting in "an average of three to five stents for each patient, more than a dozen" that "didn't need to be put out". 
 
In fact, in 2016, the average number of patients in China for interventional therapy was 1.5. "That's the number we've got through big data." Guo yanhong, deputy director of the national health and family planning commission, said it was not true that there were five or six heart stents in each patient. 
 
In guo's eyes, 1.5 is reasonable range. According to his analysis, there are many reasons to the rapid development of interventional therapy, such as national economy fast development, the state spending on health, many hospitals can afford large X-ray machine, and provides the equipment. 
 
At the same time, domestic drug research and development safeguards the process, lowers the price, and in cities such as Beijing and Shanghai, the interventional treatment has been included in the coverage of the medical insurance, reducing the cost of patients. 
 
Health and family planning commission: every case is under the "quality control" 
 
There are also questions about whether the stent is fully in the doctor's mood. Guo said the national health and family planning commission has established a quality control system for major clinical disciplines including cardiovascular disease. As of now, 36 national quality control centers have been established, and more than 1200 quality control centers have been established in various provinces and autonomous regions. 
 
"Every single case is under our quality control, and every hospital, even the 1,000 county-level hospitals that can make stents, are under our quality control system." Guo yanhong told the cover news interview. 
 
According to guo, the death rate associated with interventional treatment in China is only 0.21 percent, which is also a relatively advanced level internationally. 
 
Abuse on the county hospital heart stents can be judged by the index of operative mortality, abuse of interventional therapy if county hospital, beyond their operation level, mortality rates will tend to rise, but the county hospital mortality rate is lower than the average, show that they did not abuse. 

 
Previous article:There are 3 medical devices, the national preferential approval!
Next article:The medical representative was lost in the hospital by the "three rules"!
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網安備 44011202000029號